EMD Millipore launches enhanced Mobius 3L CellReady Bioreactor

German pharmaceutical giant Merck's life science division, EMD Millipore, has launched its 'single-use' Mobius 3L CellReady Bioreactor, for use in the development and optimisation of cell culture processes.

The firm claims the bioreactor allows “operational flexibility and enhanced process monitoring capabilities,”​ enabling perfusion and the monitoring of additional cell culture parameters, such as carbon dioxide, viable cell density or optical density.

The new model differs from previous models in three distinct ways: the Mobius 3L features an injection port for the addition of small volumes, a sub-surface fluid port for either addition or removal, and an additional port for insertion of a third probe.

The company say the Mobius 3L offers 'out-of-the-box' convenience, helping eliminate time spent on cleaning, assembly and sterilisation.

As a consequence, EMD claim the new bioreactor can reduce the turnaround time typically associated with glass models.

Related news

Show more

Related products

State-of-the-Art Virtual Pharma Factory Tour

State-of-the-Art Virtual Pharma Factory Tour

Content provided by METTLER TOLEDO | 04-May-2023 | Event Programme

Join METTLER TOLEDO’s weighing experts on a virtual tour of a state-of-the-art manufacturing facility. On the call, you'll be digitally transported...

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...